Kips Bay Medical, Inc. Fourth-Quarter and Full-Year 2012 Results Conference Call

  Kips Bay Medical, Inc. Fourth-Quarter and Full-Year 2012 Results Conference

Business Wire

MINNEAPOLIS -- March 26, 2013

Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS),
announced today that Kips Bay will release fourth-quarter and full-year ended
December 31, 2012, results on Thursday, March 28, 2013, at market close and
will hold a conference call to discuss those results at 5:00 p.m. (Eastern
Time) that day. There will be a question-and-answer session following prepared
remarks from the Company.

To ensure that you are on the call when it begins, we suggest that you access
the call approximately 5 to 10 minutes prior to the scheduled start time.

    Date:                            Thursday, March 28, 2013
        Start Time:                          5:00 p.m. Eastern Time
                                             (4:00 p.m. Central Time)
        U.S. Dial-In Number:                 1-888-679-8018
        Outside U.S. Dial-In Number:         617-213-4845
        Passcode:                            64188515
        Conference Call Host:                Brian Keogh

The conference call will be replayed for one week, starting approximately one
hour after the call ends. For callers within the United States, the replay
number is 1-888-286-8010. For callers outside the United States, the replay
number is 617-801-6888. The passcode for both of these numbers is 82473229.

A live webcast and replay of the conference call also will be available on the
company website at If you have any questions, please
call Investor Relations at Kips Bay Medical, Inc. at 763-235-3540.

About Kips Bay Medical

Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis,
Minnesota, is a medical device company focused on manufacturing and
commercializing its external saphenous vein support technology, or eSVS MESH,
for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol
mesh sleeve that, when placed over a saphenous vein graft during CABG surgery,
is designed to improve the structural characteristics and long-term
performance of the saphenous vein graft. Additional information about Kips Bay
Medical, Inc. can be found at


Kips Bay Medical, Inc.
Manny Villafaña, +1-763-235-3540
Chairman and Chief Executive Officer
Scott Kellen, +1-763-235-3540
Chief Operating Officer and Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.